PR Newswire
WARREN, N.J., March 25, 2019
WARREN, N.J., March 25, 2019 /PRNewswire/ -- Aquestive
Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated
products to solve therapeutic problems, today announced that management will present at the H.C. Wainwright Global Life Sciences
Conference to be held in London, UK on April 7 - 9.
Aquestive will present on Tuesday, April 9 at 3:20 p.m. BST. For
more information, please visit investors.aquestive.com.
About Aquestive Therapeutics
Aquestive Therapeutics is a specialty pharmaceutical company that applies innovative technology to solve therapeutic
problems and improve medicines for patients. Aquestive is advancing a late-stage proprietary product pipeline to treat CNS
conditions and provide alternatives to invasively-administered standard of care therapies. The Company also collaborates with
pharmaceutical partners to bring new molecules to market using proprietary, best-in-class technologies, like
PharmFilm®, and proven capabilities for drug development and commercialization.
Media inquiries:
Christopher Hippolyte
christopher.hippolyte@syneoshealth.com
212-364-0458
Investor inquiries:
Stephanie Carrington
stephanie.carrington@icrinc.com
646-277-1282
View original content to download multimedia:http://www.prnewswire.com/news-releases/aquestive-therapeutics-to-present-at-hc-wainwright-global-life-sciences-conference-300818029.html
SOURCE Aquestive Therapeutics, Inc.